Product Information
BUDESONIDE 0.5 MG/2 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6761 per ML under NDC 59651058530. Its NADAC has been published 57 times since Sep 3, 2025.
FDA first approved this application on Nov 29, 2023. Its Orange Book therapeutic-equivalence code is AN.
Strength
.5 mg/2mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651058530
Classification
Generic
Dosage Form
SUSPENSION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216667FDA Approved
11/29/2023
TE Code
AN
On Market Since
11/29/2023
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has been published 57 times since Sep 3, 2025, and over the history we have for it it has declined 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6761 per ML |
|---|---|
| All-time high | $0.8003 (Dec 10, 2025) |
| All-time low | $0.6761 (Sep 23, 2026) |
| 52-week high | $0.8003 |
| 52-week low | $0.6761 |
| Median price | $0.7199 |
| Average price | $0.7353 |
| Largest weekly change | -4.0% (Mar 18, 2026) |
| Weeks tracked | 57 |
| Tracking since | Sep 3, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUDESONIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BUDESONIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE 0.5 MG/2 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 0.5 MG/2 ML SUSP, manufactured by Aurobindo Pharma Limited, is $0.6761 per ML (NDC 59651058530), effective Sep 30, 2026.
How has the price of BUDESONIDE 0.5 MG/2 ML SUSP changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has declined 7.9%. It has been tracked across 57 weekly CMS publications since Sep 3, 2025.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 0.5 MG/2 ML SUSP?
Since Sep 3, 2025, the NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has ranged from a low of $0.6761 (Sep 23, 2026) to a high of $0.8003 (Dec 10, 2025), with a median of $0.7199 per ML.
Are there cheaper alternatives to BUDESONIDE 0.5 MG/2 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of BUDESONIDE 0.5 MG/2 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUDESONIDE 0.5 MG/2 ML SUSP?
BUDESONIDE 0.5 MG/2 ML SUSP (NDC 59651058530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.